• Search chemicals, activators, Inhibitors, APIs, intermediates and raw materials.

119637-67-1 (Moguisteine)

1

Identification

Moguisteine Moguisteine
Name Moguisteine
Formula C16H21NO5S
MW 339.41
CAS No. 119637-67-1
EINECS
Smiles O=C(CC(OCC)=O)N(CCS1)C1COC2=CC=CC=C2OC
Synonyms (+/-)-2-(2-Methoxyphenoxy)-methyl-3-ethoxycarbonylacetyl-1,3-thiazolidine; (R,S)-2-(2-Methoxyphenoxy)-methyl-3-ethoxycarbonyl-acetyl-1,3 thiazolidine; ethyl 3-(2-((2-methoxyphenoxy)methyl)thiazolidin-3-yl)-3-oxopropanoate
InChI InChI=1S/C16H21NO5S/c1-3-21-16(19)10-14(18)17-8-9-23-15(17)11-22-13-7-5-4-6-12(13)20-2/h4-7,15H,3,8-11H2,1-2H3
2

Introduction

Moguisteine(BBR-2173) is a novel peripheral non-narcotic antitussive drug. Target: Others Moguisteine is a novel peripheral nonnarcotic antitussive agent that has proved to be as active as codeine in several experimental models of induced cough in guinea-pigs and dogs.

Background Information

Moguisteine is a novel peripheral nonnarcotic antitussive agent that has proved to be as active as codeine in several experimental models of induced cough in guinea-pigs and dogs. ......by BOC Sciences
Moguisteine is a novel peripheral non-narcotic antitussive drug. ......by Target Molecule Corp.
3

Protocol(Only for Reference)

Cell Experiment

Animal Experiment

4

Physical and Chemical Properties

Appearance:White to off-white Solid EBNumber:EB000012046

Storage condition

Solubility

DMSO 70 mg/mL; Water <1 mg/mL by MedChemexpress Co., Ltd.
5

Mechanism and Indication

Signaling Pathways Others
Target Others
Research Area Neurological Disease
Indications
6

Clinical Information

Product Name Sponsor & Collaborators Indications Start Date End Date Phase
Moguisteine - Launched
7

Safety Data of Moguisteine

8

Spectral Information

9

Suppliers List

Company Price and Availability Country/Region
BOC Sciences
Beijing Bode United Chemical Co., Ltd. China
Biochempartner Co., Ltd China
CHEMSCENE, LLC 100mg/USD96();500mg/USD288() USA
Hebei Sande Pharmaceutical Co., Ltd. China
MedChemexpress Co., Ltd. 100mg/USD96();500mg/USD288() USA
Selleck Chemicals LLC USA
Shanghai Haoyuan Chemexpress Co., Ltd. 100mg/USD96();500mg/USD288() China
Target Molecule Corp. 50mg/USD60();100mg/USD108();250mg/USD168() USA
Wonder Synthesis (Beijing) Science and Development Co., Ltd. China
Zhejiang Esun Chemical Co., Ltd. China
10

Related Products

Other Forms of 119637-67-1

Name CAS No Formula MW

Recommended Compounds in Others

Name CAS No Formula MW
(R)-(+)-Etomoxir (sodium salt) 828934-41-4 C15H18ClNaO4 320.74
Dictamine 484-29-7 C12H9NO2 199.21
3,3',5-Triiodo-L-thyronine (sodium) 55-06-1 C15H11I3NNaO4 672.9553
Fabomotizole (hydrochloride) 173352-39-1 C15H22ClN3O2S 343.8721
FPH2 957485-64-2 C14H16ClN5O2S 353.83
α-Tocopherol (phosphate) 38976-17-9 C29H51O5P 510.69
BAMB-4 891025-25-5 C15H12N2O2 252.27
LDN-27219 312946-37-5 C20H16N4O2S2 408.5
ISO-1 478336-92-4 C12H13NO4 235.24
Aurothioglucose 12192-57-3 C6H11AuO5S 392.18
Oxybenzone 131-57-7 C14H12O3 228.24
ITX3 347323-96-0 C22H17N3OS 371.45
Cardiogreen 3599-32-4 C43H47N2NaO6S2 774.96
Skp2 Inhibitor C1 432001-69-9 C18H13BrN2O4S2 465.34
INH1 313553-47-8 C18H16N2OS 308.4
PF6-AM 1268491-69-5 C33H31BO12 630.4
XEN445 1515856-92-4 C18H17F3N2O3 366.33
Disperse Blue 148 52239-04-0 C19H19N5O4S 413.45026
Solvent Blue 35 17354-14-2 C22H26N2O2 350.454
CID-797718 370586-05-3 C12H11NO3 217.2206

Recommended Compounds in Same Indication

Name CAS No Formula MW
11

Route of Synthesis

12

References

13

More Information

Moguisteine

Tags: buy 119637-67-1 IC50 | 119637-67-1 price | 119637-67-1 cost | 119637-67-1 solubility | 119637-67-1 purchase | 119637-67-1 manufacturer | 119637-67-1 research buy | 119637-67-1 order | 119637-67-1 MSDS | 119637-67-1 chemical structure | 119637-67-1 Storage condition | 119637-67-1 molecular weight | 119637-67-1 mw | 119637-67-1 datasheet | 119637-67-1 supplier | 119637-67-1 cell line | 119637-67-1 NMR | 119637-67-1 MS | 119637-67-1 IR | 119637-67-1 solubility | 119637-67-1 Safe information | 119637-67-1 Qc and Spectral Information | 119637-67-1 Clinical Information | 119637-67-1 Clinical Trial | 119637-67-1 Route of Synthesis | 119637-67-1 storage condition | 119637-67-1 diseases and conditions | 119637-67-1 flash point | 119637-67-1 boiling point | 119637-67-1 melting point | 119637-67-1 storage condition | 119637-67-1 brand